How many institutions held BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in Q3 2022?

8 institutional investors reported BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share for Q3 2022. Use the holders table for investor-level position and value details.

BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

Q: What does CUSIP 07782B104 represent in this 13F holders report?

CUSIP 07782B104 is the security identifier for BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share used to aggregate holder disclosures.

CUSIP: 07782B104

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Ordinary Shares, par value US$0.0001 per share
Shares outstanding: 37,379,062
Total 13F shares: 115,088
Share change: +46,153
Total reported value: $3,870,578
Price per share: $33.76
Number of holders: 8
Value change: +$1,586,624
Number of buys: 7
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 07782B104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Atria Wealth Solutions, Inc.	13F	Company	0.13%	49,463	$1,540,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	8,995	$280,000	—	30 Jun 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.02%	6,640	$207,000	—	30 Jun 2022	13F
BI Asset Management Fondsmaeglerselskab A/S	13F	Company	0.01%	2,954	$92,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	0%	683	$21,000	—	30 Jun 2022	13F
Prestige Wealth Management Group LLC	13F	Company	0%	200	$6,000	—	30 Jun 2022	13F

Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q3 2022

As of 30 Sep 2022, BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 115,088 shares. The largest 8 holders included Atria Wealth Solutions, Inc., MORGAN STANLEY, STATE STREET CORP, Qube Research & Technologies Ltd, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, BARCLAYS PLC, and Prestige Wealth Management Group LLC. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.